These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 18225532)

  • 1. AlphaMbeta2 integrin modulator exerts antitumor activity in vivo.
    Suojanen J; Salo T; Sorsa T; Koivunen E
    Anticancer Res; 2007; 27(6B):3775-81. PubMed ID: 18225532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of the activated alphaMbeta2 integrin by a small molecule inhibits leukocyte migration and recruitment.
    Björklund M; Aitio O; Stefanidakis M; Suojanen J; Salo T; Sorsa T; Koivunen E
    Biochemistry; 2006 Mar; 45(9):2862-71. PubMed ID: 16503641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptides against Mac-1 do not sufficiently target leukemia or lymphoma in vivo.
    Suojanen J; Reunanen J; Ranta TM; Peñate-Medina O; Salo T; Saris P; Sorsa T
    Anticancer Res; 2014 Feb; 34(2):645-50. PubMed ID: 24510994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic acid can inhibit tongue squamous cell carcinoma invasion in vitro.
    Suojanen J; Sorsa T; Salo T
    Oral Dis; 2009 Mar; 15(2):170-5. PubMed ID: 19207486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model.
    Ho YT; Yang JS; Lu CC; Chiang JH; Li TC; Lin JJ; Lai KC; Liao CL; Lin JG; Chung JG
    Phytomedicine; 2009 Sep; 16(9):887-90. PubMed ID: 19303753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proteomics study of the serum biomarkers in tongue cancer].
    Huang X; Kang FW; Li LJ; Wen YM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Sep; 42(9):550-2. PubMed ID: 18070433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked inhibition of growth and invasive parameters of head and neck squamous carcinoma FaDu by a nutrient mixture.
    Roomi MW; Roomi NW; Kalinovsky T; Rath M; Niedzwiecki A
    Integr Cancer Ther; 2009 Jun; 8(2):168-76. PubMed ID: 19679626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective gelatinase inhibitor peptide is effective in targeting tongue carcinoma cell tumors in vivo.
    Suojanen J; Vilen ST; Nyberg P; Heikkilä P; Penate-Medina O; Saris PE; Hagström J; Ranta TM; Salo T; Sorsa T; Reunanen J
    Anticancer Res; 2011 Nov; 31(11):3659-64. PubMed ID: 22110184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model.
    Yoshida N; Ino K; Ishida Y; Kajiyama H; Yamamoto E; Shibata K; Terauchi M; Nawa A; Akimoto H; Takikawa O; Isobe K; Kikkawa F
    Clin Cancer Res; 2008 Nov; 14(22):7251-9. PubMed ID: 19010841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.
    Wang D; Veena MS; Stevenson K; Tang C; Ho B; Suh JD; Duarte VM; Faull KF; Mehta K; Srivatsan ES; Wang MB
    Clin Cancer Res; 2008 Oct; 14(19):6228-36. PubMed ID: 18829502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
    Medicherla S; Li L; Ma JY; Kapoun AM; Gaspar NJ; Liu YW; Mangadu R; O'Young G; Protter AA; Schreiner GF; Wong DH; Higgins LS
    Anticancer Res; 2007; 27(6B):4149-57. PubMed ID: 18229422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
    Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
    Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.
    Yalcin M; Bharali DJ; Lansing L; Dyskin E; Mousa SS; Hercbergs A; Davis FB; Davis PJ; Mousa SA
    Anticancer Res; 2009 Oct; 29(10):3825-31. PubMed ID: 19846915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
    Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
    Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of a tongue squamous cell carcinoma cell line (Tca8113) in vitro and in vivo via siRNA-mediated down-regulation of skp2.
    Fang L; Hu Q; Hua Z; Li S; Dong W
    Int J Oral Maxillofac Surg; 2008 Sep; 37(9):847-52. PubMed ID: 18620845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models.
    Evans S; Dizeyi N; Abrahamsson PA; Persson J
    Anticancer Res; 2009 Oct; 29(10):3917-24. PubMed ID: 19846929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.